Shinpoong Pharmaceutical rises 5.63% amid rising trend of anthelmintic drugs (Fenbendazole, etc.) theme
On the 3rd, the theme of anthelmintics (including fenbendazole) showed a strong performance, rising 3.43% compared to the previous day, while Shinpung Pharmaceutical, which is attracting attention as a related stock, surged 5.63% compared to the previous day. Shinpung Pharmaceutical is known as a pharmaceutical company focused on the sales of specialized therapeutic drugs.
[Graph] Major stock price changes in the anthelmintics (including fenbendazole) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Shinpung Pharmaceutical ranked 3rd out of 7 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Shinpung Pharmaceutical having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.
[Table] Top stocks by financial scores within the theme

※ The quant financial scores are the results of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "I Hated Myself as Much as I Craved It"... Even a Mother's Tears and Brilliant Dreams Were Shattered [ChwiYakGukga] ⑦
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Mother of Three Gang-Raped on Bus in India... Outrage as Bus Driver Implicated
- "It's Only May, but Convenience Stores Know... Iced Americano at 24°C, Tube Ice Cream at 31°C: The Thermometer of the Summer Sales Boom"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.